Hutch News

Hutch News

Stories tagged 'HIV Prevention'

Community-building leads to record enrollment in HIV prevention study

Fighting the stigma of HIV among communities of color takes trust — and time

Aug. 4, 2017 | By Mary Engel / Fred Hutch News Service

Vic Sorrell knows that the secret behind a successful HIV prevention study is spending the time to establish relationships and earn trust. A pioneer in community engagement, Sorrell works for the Vanderbilt HIV Vaccine Program, a unit of the Fred Hutch-based HIV Vaccine Trials Network.

View story >


On World AIDS Day, renewed hope for an HIV vaccine

Clinical trial taking place in South Africa could 'dramatically alter the course of the pandemic’

Dec. 1, 2016 | By Mary Engel / Fred Hutch News Service

World’s AIDS Day 2016 brings especially hopeful news: A large-scale clinical trial has opened in South Africa to test an experimental HIV vaccine regimen that could lead to the first licensed vaccine against the virus that causes AIDS.

View story >


Quest for an HIV vaccine

Community trust is key as researchers start a new trial across 15 sites in South Africa

Nov. 29, 2016 | By Mary Engel / Fred Hutch News Service

Dr. Linda-Gail Bekker, deputy director of the Desmond Tutu HIV Centre at the University of Cape Town and a member of the Fred Hutch-based HIV Vaccine Trials Network, works closely with the communities most affected by HIV to end the epidemic. She is co-chairing a just-launched clinical trial in South Africa that could lead to the first licensed HIV vaccine.

View story >


HIV prevention gains bring hope — and challenges

Injectable PrEP and other options are in the pipeline, and that makes clinical trials more complicated

Oct. 14, 2016 | By Mary Engel / Fred Hutch News Service

An injectable form of PrEP and other options are in the pipeline as the HIV field enters a new era of prevention. But such advances, as welcome as they are, come with a twist: They complicate the task of designing the clinical trials needed to test additional tools. Fred Hutch's Dr. Deborah Donnell explains.

View story >


A new path to an AIDS vaccine?

A ‘landmark’ clinical trial called the AMP study launches on three continents to test HIV-blocking super antibodies

April 7, 2016 | By Mary Engel / Fred Hutch News Service

“It’s not often that you know that you’re starting a landmark study," says Dr. Larry Corey, founder and director of the HIV Vaccine Trials Network. Two of the world’s top HIV prevention clinical trial networks have joined forces to test an experimental antibody that could potentially protect people from infection by almost all strains of the rapidly mutating AIDS virus.

View story >


Super survivors: What those with HIV who don’t get sick can teach us

Meet five ‘HIV controllers,’ some positive for decades, who may hold clues to ending AIDS

Dec. 14, 2015 | By Mary Engel / Fred Hutch News Service

Rod Fichter’s story of surviving while his partner died of AIDS was the emotional centerpiece of the HBO VICE Special Report, "Countdown to Zero." Multiply his story by 100 and you will begin to understand the exceptional volunteers who are part of a long-running Fred Hutch study on people with HIV who control the virus without medication.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.